このアイテムのアクセス数: 101

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s42003-022-03917-5.pdf6.31 MBAdobe PDF見る/開く
タイトル: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
著者: Hattori, Etsuko Yamamoto
Masuda, Tatsuya
Mineharu, Yohei  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-6346-3999 (unconfirmed)
Mikami, Masamitsu
Terada, Yukinori
Matsui, Yasuzumi
Kubota, Hirohito  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-6935-5120 (unconfirmed)
Matsuo, Hidemasa
Hirata, Masahiro
Kataoka, Tatsuki R.
Nakahata, Tatsutoshi
Ikeda, Shuji
Miyamoto, Susumu
Sugiyama, Hiroshi  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0001-8923-5946 (unconfirmed)
Arakawa, Yoshiki  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0003-4626-4645 (unconfirmed)
Kamikubo, Yasuhiko
著者名の別形: 山本(服部), 悦子
増田, 達哉
峰晴, 陽平
三上, 真充
寺田, 行範
松井, 恭澄
窪田, 博仁
松尾, 英将
平田, 勝啓
片岡, 竜貴
中畑, 龍俊
池田, 修司
宮本, 享
杉山, 弘
荒川, 芳輝
上久保, 靖彦
キーワード: Drug development
Genetic engineering
Molecular medicine
発行日: 2022
出版者: Springer Nature
誌名: Communications Biology
巻: 5
論文番号: 939
抄録: Glioblastoma is the most common adult brain tumour, representing a high degree of malignancy. Transcription factors such as RUNX1 are believed to be involved in the malignancy of glioblastoma. RUNX1 functions as an oncogene or tumour suppressor gene with diverse target genes. Details of the effects of RUNX1 on the acquisition of malignancy in glioblastoma remain unclear. Here, we show that RUNX1 downregulates p21 by enhancing expressions of BIRC5 and PIF1, conferring anti-apoptotic properties on glioblastoma. A gene switch-off therapy using alkylating agent-conjugated pyrrole-imidazole polyamides, designed to fit the RUNX1 DNA groove, decreased expression levels of BIRC5 and PIF1 and induced apoptosis and cell cycle arrest via p21. The RUNX1-BIRC5/PIF1-p21 pathway appears to reflect refractory characteristics of glioblastoma and thus holds promise as a therapeutic target. RUNX gene switch-off therapy may represent a novel treatment for glioblastoma.
著作権等: © The Author(s) 2022, corrected publication 2022
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
URI: http://hdl.handle.net/2433/284035
DOI(出版社版): 10.1038/s42003-022-03917-5
PubMed ID: 36085167
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons